Charles Retina Institute — Germantown, Tennessee

Public research footprint of Charles Retina Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetic Macular Edema · Neovascular Age-Related Macular Degeneration (nAMD) · Geographic Atrophy · Wet Age-related Macular Degeneration

Recently updated registry entries

NCT05210803 — Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for… (Enrolling By Invitation)
NCT05296447 — Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for… (Enrolling By Invitation)
NCT06961370 — A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Charles Retina Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.